FUSION PROTEINS COMPRISING SARS-COV-2 NUCLEOCAPSID DOMAINS

A fusion protein includes a SARS-CoV-2 nucleocapsid N-terminal domain and/or a SARS-CoV-2 nucleocapsid C-terminal domain, wherein the fusion protein lacks the SARS-CoV-2 nucleocapsid aggregation domain.

Saved in:
Bibliographic Details
Main Authors NASCIMENTO, ELISABETE, BOOTH, ELIZABETH A, PAVIA, EFRAIN CEH, LAPOINT, ZEBULON, MELTON WITT, JODY, HOLZ, CHARLES, WASLEY, TRISTAN
Format Patent
LanguageEnglish
Published 28.09.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A fusion protein includes a SARS-CoV-2 nucleocapsid N-terminal domain and/or a SARS-CoV-2 nucleocapsid C-terminal domain, wherein the fusion protein lacks the SARS-CoV-2 nucleocapsid aggregation domain.
Bibliography:Application Number: US202118020797